Subolesin expression in response to pathogen infection in ticks.
BACKGROUND
Ticks (Acari: Ixodidae) are vectors of pathogens worldwide that cause diseases in humans and animals. Ticks and pathogens have co-evolved molecular mechanisms that contribute to their mutual development and survival. Subolesin was discovered as a tick protective antigen and was subsequently shown to be similar in structure and function to akirins, an evolutionarily conserved group of proteins in insects and vertebrates that controls NF-kB-dependent and independent expression of innate immune response genes. The objective of this study was to investigate subolesin expression in several tick species infected with a variety of pathogens and to determine the effect of subolesin gene knockdown on pathogen infection. In the first experiment, subolesin expression was characterized in ticks experimentally infected with the cattle pathogen, Anaplasma marginale. Subolesin expression was then characterized in questing or feeding adult ticks confirmed to be infected with Anaplasma, Ehrlichia, Rickettsia, Babesia or Theileria spp. Finally, the effect of subolesin knockdown by RNA interference (RNAi) on tick infection was analyzed in Dermacentor variabilis males exposed to various pathogens by capillary feeding (CF).


RESULTS
Subolesin expression increased with pathogen infection in the salivary glands but not in the guts of tick vector species infected with A. marginale. When analyzed in whole ticks, subolesin expression varied between tick species and in response to different pathogens. As reported previously, subolesin knockdown in D. variabilis infected with A. marginale and other tick-borne pathogens resulted in lower infection levels, while infection with Francisella tularensis increased in ticks after RNAi. When non-tick-borne pathogens were fed to ticks by CF, subolesin RNAi did not affect or resulted in lower infection levels in ticks. However, subolesin expression was upregulated in D. variabilis exposed to Escherichia coli, suggesting that although this pathogen may induce subolesin expression in ticks, silencing of this molecule reduced bacterial multiplication by a presently unknown mechanism.


CONCLUSIONS
Subolesin expression in infected ticks suggested that subolesin may be functionally important for tick innate immunity to pathogens, as has been reported for the akirins. However, subolesin expression and consequently subolesin-mediated innate immunity varied with the pathogen and tick tissue. Subolesin may plays a role in tick innate immunity in the salivary glands by limiting pathogen infection levels, but activates innate immunity only for some pathogen in the guts and other tissues. In addition, these results provided additional support for the role of subolesin in other molecular pathways including those required for tissue development and function and for pathogen infection and multiplication in ticks. Consequently, RNAi experiments demonstrated that subolesin knockdown in ticks may affect pathogen infection directly by reducing tick innate immunity that results in higher infection levels and indirectly by affecting tissue structure and function and the expression of genes that interfere with pathogen infection and multiplication. The impact of the direct or indirect effects of subolesin knockdown on pathogen infection may depend on several factors including specific tick-pathogen molecular interactions, pathogen life cycle in the tick and unknown mechanisms affected by subolesin function in the control of global gene expression in ticks.
Zivkovic
Zorica
Z
Department of Infectious Diseases and Immunology, Utrecht Centre for Tick-borne Diseases, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL Utrecht, The Netherlands. Z.Zivkovic@uu.nl
Torina
Alessandra
A
Mitra
Ruchira
R
Alongi
Angela
A
Scimeca
Salvatore
S
Kocan
Katherine M
KM
Galindo
Ruth C
RC
Almazán
Consuelo
C
Blouin
Edmour F
EF
Villar
Margarita
M
Nijhof
Ard M
AM
Mani
Rinosh
R
La Barbera
Giuseppa
G
Caracappa
Santo
S
Jongejan
Frans
F
de la Fuente
José
J
D000818:Animals; D000941:Antigens / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D060829:Arthropod Proteins; D001419:Bacteria / Q000276:immunology* / Q000472:pathogenicity; D001424:Bacterial Infections / Q000276:immunology*; D003870:Dermacentor / Q000276:immunology; D029721:Drosophila Proteins / Q000235:genetics; D019143:Evolution, Molecular; D054884:Host-Pathogen Interactions; D007113:Immunity, Innate; D007303:Insect Vectors; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000276:immunology / Q000473:pathology; D008018:Life Cycle Stages; D009687:Nuclear Proteins; D034741:RNA, Small Interfering / Q000235:genetics; D012469:Salivary Glands / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D013987:Ticks / Q000276:immunology / Q000378:metabolism* / Q000382:microbiology; D014774:Virulence
D000941:Antigens; D060829:Arthropod Proteins; D029721:Drosophila Proteins; D009687:Nuclear Proteins; D034741:RNA, Small Interfering; C526726:akirin protein, Drosophila; C550207:subolesin, tick